Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118300836 | 11830083 | 6 | F | 2010 | 20160809 | 20151213 | 20160822 | EXP | GB-CIPLA LTD.-2015GB09207 | CIPLA | 0.00 | Y | 0.00000 | 20160822 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118300836 | 11830083 | 1 | PS | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | UNK | U | U | 77955 | ||||||||
| 118300836 | 11830083 | 2 | SS | HERCEPTIN | TRASTUZUMAB | 1 | Subcutaneous | 450 MG, UNK | U | U | B1010B08, B00442B01,B104B13 | 0 | 450 | MG | |||||
| 118300836 | 11830083 | 3 | SS | HERCEPTIN | TRASTUZUMAB | 1 | Subcutaneous | 600 MG, UNK | U | U | B1010B08, B00442B01,B104B13 | 0 | 600 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118300836 | 11830083 | 1 | Product used for unknown indication |
| 118300836 | 11830083 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118300836 | 11830083 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118300836 | 11830083 | Arthralgia | |
| 118300836 | 11830083 | Bladder irritation | |
| 118300836 | 11830083 | Blood pressure increased | |
| 118300836 | 11830083 | Dizziness | |
| 118300836 | 11830083 | Dry skin | |
| 118300836 | 11830083 | Dysuria | |
| 118300836 | 11830083 | Fall | |
| 118300836 | 11830083 | Fatigue | |
| 118300836 | 11830083 | Feeling abnormal | |
| 118300836 | 11830083 | Gingival pain | |
| 118300836 | 11830083 | Head injury | |
| 118300836 | 11830083 | Hepatic neoplasm | |
| 118300836 | 11830083 | Joint swelling | |
| 118300836 | 11830083 | Lacrimation increased | |
| 118300836 | 11830083 | Local swelling | |
| 118300836 | 11830083 | Musculoskeletal stiffness | |
| 118300836 | 11830083 | Myalgia | |
| 118300836 | 11830083 | Nasal congestion | |
| 118300836 | 11830083 | Neoplasm progression | |
| 118300836 | 11830083 | Neuralgia | |
| 118300836 | 11830083 | Onychoclasis | |
| 118300836 | 11830083 | Pain in extremity | |
| 118300836 | 11830083 | Photophobia | |
| 118300836 | 11830083 | Pruritus | |
| 118300836 | 11830083 | Rhinorrhoea | |
| 118300836 | 11830083 | Sinus pain | |
| 118300836 | 11830083 | Skin abrasion | |
| 118300836 | 11830083 | Trigeminal neuralgia | |
| 118300836 | 11830083 | Urinary retention | |
| 118300836 | 11830083 | Urine flow decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |